Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,211 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07615010RecruitingPhase 2
agenT-797 Plus Standard Care for Severe Pneumonia With Respiratory Failure
This trial tests whether adding an experimental drug called agenT-797 to standard pneumonia treatment helps patients in the ICU who have severe pneumonia and serious difficulty breathing (acute hypoxemic respiratory failure). The drug is designed to help the immune system fight severe infection.
San Francisco, CaliforniaAges 18 years+ - NCT07615426RecruitingPhase 1
Testing aticaprant with antipsychotic medication for schizophrenia
This study tests whether a new medication called aticaprant is safe and well-tolerated when added to your current antipsychotic medication for schizophrenia. The goal is to see if it could help improve symptoms without causing serious side effects.
Garden Grove, CaliforniaAges 18–55 - NCT07615673Recruiting
Artichoke supplement study measuring body markers
This study tests an artichoke by-product supplement to see how your body processes and uses it. Researchers will measure markers in your blood and other samples to understand how the supplement affects your digestive health and metabolism.
Pamplona, NavarreAges 18–75 - NCT07621237RecruitingPhase 2
TNX-102 SL for Major Depressive Disorder
This study tests whether a new medication called TNX-102 SL can reduce depression symptoms better than a placebo (inactive pill). You'll take the medication daily and have regular check-ins to see how you're doing.
Phoenix, ArizonaAges 18 years+ - NCT07628998Recruiting
Text Messages to Encourage Colorectal Cancer Screening
This study tests whether reminder text messages help people complete colorectal cancer screening. You would receive SMS messages encouraging you to schedule a screening test if you haven't done so after an initial invitation.
Sabadell, CataloniaAges 50–69 - NCT07632378Recruiting
Vagus Nerve Stimulation and Stomach Movement Study
This study tests whether stimulating the vagus nerve (a major nerve in your body) with a small electrical device affects how your stomach moves and processes food. Researchers want to understand this effect in healthy people to potentially help those with digestive problems in the future.
Maastricht, LimburgAges 18–55 - NCT07632456Recruiting
Ear Stimulation Device for Nausea Management
This study tests whether a small device that gently stimulates a nerve in your ear can help reduce nausea. Researchers will enroll healthy adults to see if this non-drug approach is safe and effective.
Maastricht, LimburgAges 18–65 - NCT07633288RecruitingPhase 2
AP1189 Safety and Efficacy for Severe Respiratory Viral Infection
This trial tests whether an experimental drug called AP1189, added to standard hospital care, can help people hospitalized with severe breathing problems from viruses like COVID-19, flu, or RSV. The goal is to see if it reduces the need for mechanical ventilation or other life support.
Mostar, Herzegovina-Neretva CantonAges 18 years+ - NCT07641309Recruiting
Health Program for Diabetes, Lung, or Heart Disease
This study measures how a health improvement program helps people with type 2 diabetes, chronic lung disease, or heart disease. Researchers will track your health before and after you participate in the program offered by your local municipality.
FrederiksværkAges 18 years+ - NCT07641634RecruitingPhase 1/Phase 2
Testing PRO-203 for active systemic sclerosis
This trial tests a new investigational medicine called PRO-203 for people with systemic sclerosis (scleroderma). It aims to see if the medicine can help control active disease that hasn't responded to other treatments.
Melbourne, VictoriaAges 18–65 - NCT07644702Recruiting
Community health forums to increase breast cancer screening
This study invites rural and low-income women to join free community forums that teach about breast cancer screening and clinical trials. The goal is to help more women get mammograms (breast X-rays) and learn about research opportunities that might benefit their health.
Eau Claire, WisconsinAges 50–74 - NCT07646587RecruitingPhase 2
Safety Study of WIN378 for Moderate-Severe COPD
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
Miami Lakes, FloridaAges 40–80 - NCT07647783RecruitingPhase 1
Safety Study of SYH2072 Tablet in Healthy Adults
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
Beijing, Beijing MunicipalityAges 18–55 - NCT07650058Recruiting
How Fresh Mango Affects Blood Sugar in Breakfast
This study tests whether eating fresh mango instead of sugar in breakfast affects how your body handles blood sugar. Researchers want to understand if mango is a healthier breakfast option for young, generally healthy adults.
Muncie, IndianaAges 18–45 - NCT07652658RecruitingPhase 2
Study of AZD8965 for people with IPF
This trial tests a new drug called AZD8965 for Idiopathic Pulmonary Fibrosis (IPF). It aims to see if the drug can help people with IPF either on current treatments or not on standard therapy.
Birmingham, AlabamaAges 40 years+ - NCT07656688RecruitingPhase 2
Finding the best dose for a dry eye treatment
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
SeoulAges 19 years+ - NCT07656727RecruitingPhase 2
A study of BGE-102 for obesity and heart risk
This trial tests an experimental drug called BGE-102 in people with obesity and signs of inflammation. It aims to see if the drug can help reduce body weight and improve heart health. Participants must be willing to keep a stable diet and exercise routine.
Chandler, ArizonaAges 18 years+ - NCT07660614RecruitingPhase 1/Phase 2
Testing a new drug for people with ALS
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
LübeckAges 18–75 - NCT07667088Recruiting
Whitening mouthwash using oil pulling
This study tests a whitening mouthwash that uses an oil-pulling method. It lasts a few months and compares the mouthwash to not using any whitening product. If you have naturally darker front teeth and haven't whitened them recently, this might be an option for you.
San Antonio, TexasAges 18–60 - NCT07667322RecruitingPhase 1
Study of a new under-the-skin multiple sclerosis treatment
This trial tests a new way to give ocrelizumab, an approved MS treatment, as a shot under the skin instead of through an IV. It aims to see if it's safe and works well for people with relapsing or primary progressive MS.
Carlsbad, CaliforniaAges 18–65 - NCT07669168Recruiting
Health study comparing usual care vs. extra support
This study looks at whether adding extra health support helps people stay healthier over time. You would be followed for a while and asked to share how you are doing.
Boulder, ColoradoAges 18 years+ - NCT07644676Enrolling by invitation
Comparing Bonding Methods for Dental Crowns
This study tests different ways to attach a crown to your back tooth to see which method works best and lasts longest. If you need a single crown and have healthy teeth and gums, you may be able to participate.
Hörby, Skåne CountyAges 18 years+ - NCT07642401Enrolling by invitation
Building models to understand esophageal cancer
This research study uses medical records and imaging from patients with various esophageal conditions—from inflammation to cancer—to develop better diagnostic and prediction tools. Researchers want to understand what changes in the esophagus lead to cancer and how to catch it earlier.
Anyang, HenanAges 18–90 - NCT07580586RecruitingPhase 1
Study of BV100's effect on polymyxin B in healthy volunteers
This early-stage study tests how a new drug called BV100 affects how your body processes polymyxin B, an antibiotic. Researchers want to understand how these two drugs interact so they can develop safer treatments.
ViennaAges 18–55
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,211 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.